![](https://www.diabetesnews.com/wp-content/uploads/2012/09/light-virus-1-150x150.jpg)
Researchers are looking at whether DPP4 inhibitors, a class of diabetes drugs, may be useful in treating COVID-19. There is some research indicating that DPP4 is directly involved in the cell adhesion and virulence of the virus causing COVID-19, which means inhibition of DPP4 may help treat this novel coronavirus. Read more